We are live on ! Find out more
HKIM

Hayek Kallen Investment Management Portfolio holdings

AUM $307M
1-Year Est. Return 18.5%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+18.5%
3 Year Est. Return
+68.46%
5 Year Est. Return
+97.89%
10 Year Est. Return
+297.02%
AUM
$121M
AUM Growth
+$2.75M
Cap. Flow
+$65K
Cap. Flow %
0.05%
Top 10 Hldgs %
39.91%
Holding
60
New
2
Increased
10
Reduced
43
Closed

Top Buys

Rank Stock Value
1
HRI icon
Herc Holdings
HRI
+$1.88M
2
INTC icon
Intel
INTC
+$880K
3
ACN icon
Accenture
ACN
+$292K
4
NSC icon
Norfolk Southern
NSC
+$225K
5
ORCL icon
Oracle
ORCL
+$125K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$269K
2
XOM icon
ExxonMobil
XOM
+$260K
3
JNJ icon
Johnson & Johnson
JNJ
+$248K
4
NVS icon
Novartis
NVS
+$246K
5
MSFT icon
Microsoft
MSFT
+$161K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.38%
2 Healthcare 19.35%
3 Technology 13.36%
4 Industrials 10.84%
5 Energy 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
26
Target
TGT
$69.9B
$1.95M 1.61%
30,543
-413
-1% -$28.1K
ORCL icon
27
Oracle
ORCL
$442B
$1.81M 1.5%
54,715
+3,860
+8% +$125K
HRI icon
28
Herc Holdings
HRI
$5.63B
$1.63M 1.35%
+24,563
New +$1.88M
BTU
29
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$1.45M 1.2%
5,609
-370
-6% -$94.6K
SO icon
30
Southern Company
SO
$106B
$1.42M 1.17%
34,476
-137
-0.4% -$5.9K
QCOM icon
31
Qualcomm
QCOM
$171B
$1.37M 1.14%
20,411
-160
-0.8% -$10.5K
EXC icon
32
Exelon
EXC
$46.6B
$1.32M 1.09%
62,396
-4,094
-6% -$89.6K
UNP icon
33
Union Pacific
UNP
$174B
$1.15M 0.95%
14,756
-196
-1% -$15.5K
PFE icon
34
Pfizer
PFE
$150B
$1.1M 0.91%
40,311
+3,125
+8% +$85K
CL icon
35
Colgate-Palmolive
CL
$73.6B
$1.09M 0.9%
18,345
+328
+2% +$19.4K
MRO
36
DELISTED
Marathon Oil Corporation
MRO
$1.08M 0.89%
30,976
-2,147
-6% -$76.4K
VALE icon
37
Vale
VALE
$61.4B
$1M 0.83%
64,151
-1,725
-3% -$25.5K
SLB icon
38
SLB Ltd
SLB
$78.1B
$922K 0.76%
10,429
-1,099
-10% -$90.3K
CVX icon
39
Chevron
CVX
$386B
$878K 0.73%
7,226
-1,004
-12% -$123K
ABT icon
40
Abbott
ABT
$192B
$848K 0.7%
25,540
-1,148
-4% -$40.3K
PRA
41
DELISTED
ProAssurance
PRA
$837K 0.69%
18,576
-1,000
-5% -$50.1K
CVS icon
42
CVS Health
CVS
$121B
$689K 0.57%
12,142
-298
-2% -$17.8K
ADM icon
43
Archer Daniels Midland
ADM
$38.4B
$666K 0.55%
18,068
-2,276
-11% -$82.9K
ABBV icon
44
AbbVie
ABBV
$440B
$643K 0.53%
14,384
-495
-3% -$21.9K
MDLZ icon
45
Mondelez International
MDLZ
$79.4B
$536K 0.44%
17,055
-1,915
-10% -$59.4K
GL icon
46
Globe Life
GL
$13.8B
$512K 0.42%
10,614
-84
-0.8% -$3.95K
D icon
47
Dominion Energy
D
$59.8B
$469K 0.39%
7,502
+672
+10% +$39.9K
T icon
48
AT&T
T
$166B
$411K 0.34%
16,080
-1,732
-10% -$45.5K
COP icon
49
ConocoPhillips
COP
$153B
$378K 0.31%
5,444
-380
-7% -$25.4K
WDR
50
DELISTED
Waddell & Reed Financial, Inc.
WDR
$349K 0.29%
6,786

Similar funds

Hayek Kallen Investment Management's Q3 2013 Portfolio in Review

As of Q3 2013, Hayek Kallen Investment Management held 60 positions worth $121M, up 2.3% from $118M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q3 2013: portfolio turnover was 3.3%. Hayek Kallen Investment Management opened 2 new positions and made no exits, leaving the 60-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.

  • Hayek Kallen Investment Management's largest Q3 2013 buy was Herc Holdings: 24,563 shares worth $1.63M.
  • Hayek Kallen Investment Management added most to Intel in Q3 2013, an estimated $880K increase.
  • Hayek Kallen Investment Management's biggest Q3 2013 reduction was Thermo Fisher Scientific, cutting an estimated $269K.
  • Hayek Kallen Investment Management's ten largest holdings make up 40% of its $121M portfolio in Q3 2013.
  • Hayek Kallen Investment Management opened 2 new positions and closed 0 in Q3 2013.
  • Hayek Kallen Investment Management's portfolio value rose 2.3% quarter-over-quarter to $121M.

Based on Hayek Kallen Investment Management's 13F filing for Q3 2013, filed 8 Nov 2013.